Jiangxi Sanai Pharmaceutical Co., Ltd. is a professional trading company and manufacturer based in Yichun, China, specializing in the health and personal care sector. Established in 2018, the company focuses on the development and distribution of feminine hygiene and wellness products, including gynecological gels, cleansing pills, vaginal tightening solutions, and antibacterial lotions. Their diverse product portfolio also extends to male care products, herbal capsules, essential oils, and specialized insecticides. Jiangxi Sanai Pharmaceutical Co., Ltd. provides OEM services, offering flexible customization and production capabilities to meet specific client requirements. The company maintains a workforce of 11 to 50 employees and holds CE certification, reflecting a commitment to international quality standards for its range of herbal and natural formulations. Their operations cater to both domestic and international markets with a focus on high-demand personal care and pharmaceutical categories.
Own brandOwns and operates its own brands and manufacturing facilities.
Curious about this supplier? Ask AI for a quick overview.
Key export market
OceaniaOceania
EuropeEurope
South AmericaSouth America
North AmericaNorth America
Insights
Product review score distribution
Reflecting the quality of suppliers' goods and the satisfaction of user feedback
All categories
Loading chart data...
Product review score distribution
This insight is only available after unlocked
Similar suppliers you may like
Jiangxi Institute of Biological Products Inc.
🇨🇳 China
196951-100 peopleManufacturer/Trading Company/Service Company
Established brand
High-tech enterprise
Patented technology
Own brand
Shipments
10
Key customer
SAHAR
Key market
Africa
Description
Jiangxi Institute of Biological Products Inc. is a leading Chinese manufacturer, trading company, and service provider specializing in biological products, particularly antitoxins and immune sera. Established in 1969, the company has nearly 50 years of experience and operates as a National High-tech Enterprise with a workforce of 51-100 employees. With a registered capital of RMB 102 million and total assets exceeding RMB 300 million, the company operates modern, GMP-compliant biopharmaceutical platforms across multiple sites in Ji'an, China, including a 20,000m² factory building and the largest Experimental Animal Center in Jiangxi. They are recognized as the largest producer, researcher, and seller of antitoxins and immune sera in China, holding over 70% domestic market share for Tetanus Antitoxin and ranking first in production capacity for this product. The company offers OEM services and holds GMP, Veterinary GMP, CMA, and GLP certifications. Their extensive product portfolio includes human biological products like Tetanus Antitoxin (1500IU, 3000IU, 5000IU, 10000IU), ATS Injection, and ATS Antisera, as well as veterinary medicines such as Cloprostenol Sodium Injection, Progesterone Injection, and Pregnant Mare Serum Gonadotropin (PMSG). They also engage in the development of antivenoms and anti-rabies serum, and offer equine byproducts like horse oil and horse hair. Jiangxi Institute of Biological Products Inc. exports to over 20 countries and regions, with an exporter percentage of 21-30%, and reported revenues of RMB 220.8 million (USD 30.2 million) in 2024. The company invests significantly in R&D, holding 48 patents, and collaborates with academic institutions for immunology research.
Tetanus Antitoxin
Jiangxi RV Pharmaceutical Co., Ltd.
🇨🇳 China
201051-100 peopleManufacturer
ODM manufacturer
Product customization
High-tech enterprise
OEM manufacturer
Key market
Europe
Description
Jiangxi RV Pharmaceutical Co., Ltd. is a research-oriented manufacturer established in July 2010, specializing in the R&D, production, and marketing of high-end pharmaceutical intermediates, fine chemicals, and electronic chemicals. Based in the Guixi Sulfur Phosphorus Chemical Park in Jiangxi, China, the company operates a 26,000-square-meter facility featuring four Class A synthesis workshops equipped with 100 reaction kettles. With a workforce of approximately 80 to 100 employees, the enterprise provides comprehensive OEM and ODM services alongside technical support for domestic and international pharmaceutical firms.
The company's core product portfolio includes Sarpogrelate Hydrochloride and its intermediates, Lumefantrine, Lafutidine, and 2-Cyanopyrimidine. They are particularly recognized for their technical expertise in phenylacetylene derivatives, such as 3-Bromo-phenylacetylene and 4-Bromo-phenylacetylene, as well as 2,5-Dihydroxy benzaldehyde and Dimethyl 1,3-acetonedicarboxylate. Jiangxi RV Pharmaceutical maintains a strong market presence by leveraging advanced manufacturing technologies to ensure high quality and cost-efficiency. Their products are widely exported to international markets, including Southeast Asia, North America, and Europe.